Global Information
회사소개 | 문의 | 비교리스트

피부암 치료 분야 : 거래 애널리틱스

Skin Cancers Therapeutics Area - Deals Analytics H2 2020 Report

리서치사 GervanoRA Data Services LLP
발행일 2020년 11월 상품 코드 968651
페이지 정보 영문 63 Pages
가격
US $ 1,250 ₩ 1,401,000 PDF (Single User License)
US $ 1,800 ₩ 2,018,000 PDF (Site License)
US $ 2,500 ₩ 2,803,000 PDF (Global License)


피부암 치료 분야 : 거래 애널리틱스 Skin Cancers Therapeutics Area - Deals Analytics H2 2020 Report
발행일 : 2020년 11월 페이지 정보 : 영문 63 Pages

본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

피부암 치료 분야에 대해 조사분석했으며, 파트너 상황의 전체적인 경쟁에 관한 정보를 정리하여 전해드립니다.

조사 내용 :

  • 거래 유형 기반 애널리틱스
  • 거래 기반 애널리틱스 : 금액별
  • 거래 지역 기반 애널리틱스
  • 거래업체 기반 애널리틱스
  • 매년 애널리틱스
  • 거래 빈도 기반 애널리틱스
  • 가동중 거래 기업 기반 애널리틱스
  • 제휴 거래, 금융거래, 라이선스 거래, M&A 거래에 중점을 둔 애널리틱스

목차

제1장 피부암의 개요

  • 서론
  • 치료 알고리즘·가이드라인
  • 역학연구
    • 세계의 동향·역사적 동향

제2장 피부암의 시장 역학, 경쟁 분야

  • 거래(합병/인수/제휴)
    • 거래 애널리틱스 : 거래 유형별
    • 거래 애널리틱스 : 연간 빈도별
    • 거래 애널리틱스 : 가동중 기업별
KSA 20.11.19

GervanoRA's 'Skin Cancers Therapeutics Areas - Deals Analytics H2 2020 Report' has analyzed and provided an understanding of the overall competition in partnering landscape in the disease area that has occurred from the year 2010.

GervanoRA has analyzed more than 681 drug candidates in the current development pipeline. Hence, a number of emerging and clinical-stage companies are embarking with collaborations or partnerships with different pharma companies to aid in the development process of their respective drug candidates. In the light of rocketing competition, not only companies, but also universities, institutes and research centers are getting actively involved in the advancements of new medicines for the treatment of the disease.

The report through its meticulous analysis on global therapeutic landscape of Skin Cancers Therapeutics Areas deals assists companies in taking future partnering decisions based on competitor's R&D activities; current trends in partnering landscape in order to avoid or mitigate competitive market risks.

For a proper understanding, GervanoRA has segmented the report into sections based on:

  • Analytics Based on Deal Type,
  • Analytics Based on Deal by Value,
  • Analytics Based on Deal Geography
  • Analytics Based on Deal Maker
  • Year-by-Year Analytics
  • Analytics Based on Deal Frequency
  • Analytics Based on Deal Active Player
  • Analytics Based on More Emphasis on Collaboration Deals, Financing Deals, Licensing Deals, Merger & Acquisition Deals.

The report also includes Brief over view on Skin Cancers and Skin Cancer Types, and Epidemiological Studies.

TABLE OF CONTENTS

CHAPTER 01: SKIN CANCERS OVERVIEW 4

  • 1.1. INTRODUCTION 4
  • 1.2. TREATMENT ALGORITHM AND GUIDELINES 7
  • 1.3. EPIDEMIOLOGY STUDIES 14
    • 1.3.1. GLOBAL AND HISTORICAL TRENDS 15
      • 1.3.1.1. UNITED STATES 17
      • 1.3.1.2. AUSTRALIA 18
      • 1.3.1.3. EUROPE 19

CHAPTER 02: MARKET DYNAMICS OF SKIN CANCERS COMPETITIVE SPACE 21

  • 2.1. DEALS (MERGERS/ ACQUISITIONS/ COLLABORATIONS) 21
    • 2.1.1 DEALS ANALYTICS BY DEAL TYPE 21
      • 2.1.1.1. COLLABORATION DEALS 22
      • 2.1.1.2. FINANCING DEALS 37
      • 2.1.1.3. LICENSING DEALS 43
      • 2.1.1.4. MERGER AND ACQUISITION DEALS 50
    • 2.1.2 DEALS ANALYTICS BY ANNUAL FREQUENCY 57
    • 2.1.3 DEALS ANALYTICS BY ACTIVEPLAYER 58
Back to Top
전화 문의
F A Q